Adenovirus 5-fiber 35 chimeric vector mediates efficient apical correction of the cystic fibrosis transmembrane conductance regulator defect in cystic fibrosis primary airway epithelia

Human Gene Therapy

Volumn 21, Issue 3, 2010, Pages 251-269

  Granio, Ophélia ^a   Excoffon, Katherine J D Ashbourne ^b   Henning, Petra ^c,d   Melin, Patricia ^e   Norez, Caroline ^e   Gonzalez, Gaëlle ^a   Karp, Philip H ^b   Magnusson, Maria K ^c,d   Habib, Nagy ^f   Lindholm, Leif ^c,d   Becq, Frédéric ^e   Boulanger, Pierre ^a   Zabner, Joseph ^b   Hong, Saw See ^a  

^a UNIVERSITÉ LYON 1   (France)

^b UNIVERSITY OF IOWA   (United States)

^c Got A Gene AB ^*  (Sweden)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

^e UNIVERSITÉ DE POITIERS   (France)

^f IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ARGINYLGLYCYLASPARTIC ACID; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ADENOVIRUS 5; ARTICLE; CHIMERA; CONTROLLED STUDY; CYSTIC FIBROSIS; DOSE RESPONSE; GENE TRANSFER; HUMAN; HUMAN CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN SYNTHESIS; RESPIRATORY EPITHELIUM;

ADENOVIRIDAE; ADULT; BLOTTING, WESTERN; CAPSID PROTEINS; CELLS, CULTURED; CHLORIDES; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; ENDOCYTOSIS; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GENOME, VIRAL; GREEN FLUORESCENT PROTEINS; HUMANS; INTEGRINS; MUTATION; RESPIRATORY MUCOSA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSGENES;

ADENOVIRIDAE; HUMAN ADENOVIRUS TYPE 5; MIRIDAE;

EID: 77949675351     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2009.056     Document Type: Article

References (81)

1. Ashbourne Excoffon, K.J.D., Moninger, T., and Zabner, J. (2003). The coxsackie B virus and adenovirus receptor resides in a distinct membrane microdomain. J. Virol. 77, 2559-2567.
2. Boulanger, P., Lemay, P., Blair, G.E., and Russell, W.C. (1979). Characterization of adenovirus protein IX. J. Gen. Virol. 44, 783-800.
3. Boulanger, P.A., and Puvion, F. (1973). Large-scale preparation of soluble adenovirus hexon, penton and fiber antigens in highly purified form. Eur. J. Biochem. 39, 37-42.
4. Boulanger, P.A., Devaux, C., and Loucheux-Lefebvre, M.H. (1977). Comparative optical properties of free and assembled hexon capsomers of human adenovirus type 2. FEBS Lett. 85, 52-56.
5. Bowen, G.P., Borgland, S.L., Lam, M., Libermann, T.A., Wong, N.C., and Muruve, D.A. (2002). Adenovirus vector-induced inflammation: Capsid-dependent induction of the C-C che-mokine RANTES requires NF-kB. Hum. Gene Ther. 13, 367-379.
6. Bradbury, N.A. (1999). Intracellular CFTR: Localization and function. Physiol. Rev. 79, S175-S191.
7. Buckley, S.M., Waddington, S.N., Jezzard, S., Bergau, A., Themis, M., Macvinish, L.J., Cuthbert, A.W., Colledge, W.H., and Coutelle, C. (2008). Intra-amniotic delivery of CFTR-expressing adenovirus does not reverse cystic fibrosis phenotype in inbred CFTR-knockout mice. Mol. Ther. 16, 819-824.
8. Cerullo, V., Seiler, M.P., Mane, V., Brunetti-Pierri, N., Clarke, C., Bertin, T.K., Rodgers, J.R., and Lee, B. (2007). Toll-like receptor 9 triggers an innate immune response to helper-dependent adenoviral vectors. Mol. Ther. 15, 378-385.
9. Davies, L.A., Varathalingam, A., Painter, H., Lawton, A.E., Sumner-Jones, S.G., Nunez Alonso, G.A., Chan, M., Mun-konge, F., Alton, E.W., Hyde, S.C., and Gill, D.R. (2008). Adenovirus-mediated in utero expression of CFTR does not improve survival of CFTR knockout mice. Mol. Ther. 16, 812-818.
10. 1-mediated adenovirus infection is enhanced by the integrin-activating antibody TS2=16. J. Virol. 71, 6204-6207.
11. 1 integrin function. J. Gene Med. 3, 550-559.
12. Defer, C., Belin, M.-T., Caillet-Boudin, M.-L., and Boulanger, P. (1990). Human adenovirus-host cell interactions: Comparative study with members of subgroups B and C. J. Virol. 64, 3661-3673.
13. Derand, R., Bulteau-Pignoux, L., Mettey, Y., Zegarra-Moran, O., Howell, L.D., Randak, C., Galietta, L.J., Cohn, J.A., Norez, C., Romio, L., Vierfond, J.M., Joffre, M., and Becq, F. (2001). Activation of G551D CFTR channel with MPB-91: Regulation by ATPase activity and phosphorylation. Am. J. Physiol. Cell Physiol. 281, C1657-C1666.
14. D'Halluin, J.-C. (1995). Virus assembly. Curr. Top. Microbiol. Immunol. 199, 47-66.
15. D'Halluin, J.C., Martin, G.R., Torpier, G., and Boulanger, P.A. (1978). Adenovirus type 2 assembly analyzed by reversible cross-linking of labile intermediates. J. Virol. 26, 357-363.
16. Dormer, R.L., Derand, R., McNeilly, C.M., Mettey Y, Bulteau-Pignoux, L., Metaye, T., Vierfond, J., Gray, M.A., Galietta, L.J., Morris, M.R., Pereira, M.M., Doull, I.J.M., Becq, F., and McPherson, M.A. (2001). Correction of delF508-CFTR activity with benzo(c)quinolizinium compounds through facilitation of its processing in cystic fibrosis airway cells. J. Cell Sci. 114, 4073-4081.
17. Duan, D., Yue, Y., Yan, Z., Yang, J., and Engelhardt, J.F. (2000). Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virus. J. Clin. Invest. 105, 1573-1587.
18. Excoffon, K.J., Guglielmi, K.M., Wetzel, J.D., Gansemer, N.D., Campbell, J.A., Dermody, T.S., and Zabner, J. (2008). Reovirus preferentially infects the basolateral surface and is released from the apical surface of polarized human respiratory epithelial cells. J. Infect. Dis. 197, 1189-1197.
19. Farmen, S.L., Karp, P.H., Ng, P., Palmer, D.J., Koehler, D.R., Hu, J., Beaudet, A.L., Zabner, J., and Welsh, M.J. (2005). Gene transfer of CFTR to airway epithelia: Low levels of expression are sufficient to correct Cl~ transport and overexpression can generate basolateral CFTR. Am. J. Physiol. Lung Cell. Mol. Physiol. 289, L1123-L1130.
20. Franqueville, L., Henning, P., Magnusson, M.K., Vigne, E., Schoehn, G., Blair-Zajdel, M.E., Habib, N., Lindholm, L., Blair, G.E., Hong, S.S., and Boulanger, P. (2008). Protein crystals in adenovirus type 5-infected cells: Requirements for intranuclear crystallogenesis, structural and functional analysis. PLoS One 3, e2894.
21. Gaden, F., Franqueville, L., Hong, S.S., Legrand, V., Figarella, C, and Boulanger, P. (2002). Mechanism of restriction of normal and cystic fibrosis transmembrane conductance regulator deficient human tracheal gland cells to adenovirus (Ad) infection and Ad-mediated gene transfer. Am. J. Respir. Cell Mol. Biol. 27, 628-640.
22. Gaden, F., Franqueville, L., Magnusson, M.K., Hong, S.S., Mer-ten, M.D., Lindholm, L., and Boulanger, P. (2004). Gene transduction and cell entry pathway of fiber-modified adenovirus type 5 vectors carrying novel endocytic peptide li-gands selected on human tracheal glandular cells. J. Virol. 78, 7227-7247.
23. Gaggar, A., Shayakhmetov, D.M., and Lieber, A. (2003). CD46 is a cellular receptor for group B adenoviruses. Nat. Med. 8, 746-755.
24. Ganesh, S., Gonzalez-Edick, M., Gibbons, D., Waugh, J., Van-roey, M., and Jooss, K. (2009). Evaluation of biodistribution of a fiber chimeric, conditionally replication-competent (oncolytic) adenovirus in CD46 receptor transgenic mice. Hum. Gene Ther. 20, 1201-1213.
25. Granio, O., Norez, C, Asbourne Excoffon, K.J.D., Karpp, P., Lusky, M., Becq, F., Boulanger, P., Zabner, J., and Hong, S.S. (2007). Cellular localization and activity of GFP tagged CFTR transduced by adenovirus in CFTR-deficient cells. Am. J. Respir. Cell Mol. Biol. 37, 631-639.
26. Granio, O., Porcherot, M., Corjon, S., Kitidee, K., Henning, P., Eljaafari, A., Cimarelli, A., Lindholm, L., Miossec, P., Boulanger, P., and Hong, S.S. (2009). Improved adenovirus type 5 vector-mediated transduction of resistant cells by piggybacking on coxsackie B-adenovirus receptor-pseudotyped bacu-lovirus. J. Virol. 83, 6048-6066.
27. Green, M., Piñ a, M., and Kimes, R.C. (1967). Biochemical studies on adenovirus multiplication. XII. Plaquing efficiencies of purified human adenoviruses. Virology 31, 562-565.
28. Greig, J.A., Buckley, S.M., Waddington, S.N., Parker, A.L., Bhella, D., Pink, R., Rahim, A.A., Morita, T., Nicklin, S.A., McVey, J.H., and Baker, A.H. (2009). Influence of coagulation factor X on in vitro and in vivo gene delivery by adenovirus (Ad) 5, Ad35, and chimeric Ad5=Ad35 vectors. Mol. Ther. 17, 1683-1691.
29. Hartman, Z.C., Black, E.P., and Amalfitano, A. (2007). Adeno-viral infection induces a multi-faceted innate cellular immune response that is mediated by the Toll-like receptor pathway in A549 cells. Virology 358, 357-372.
30. Henning, P., Magnusson, M.K., Gunneriusson, E., Hong, S.S., Boulanger, P., and Lindholm, L. (2002). Genetic modification of adenovirus 5 tropism by a novel class of ligands based on a three-helix bundle scaffold derived from staphylococcal protein A. Hum. Gene Ther. 13, 1427-1439.
31. Henning, P., Andersson, K.M.E., Frykholm, K., ALI, A., Mag nusson, M.K., Nygren, P.-A., Granio, O., Hong, S.S., Bou-langer, P., and Lindholm, L. (2005). Tumor cell targeted gene delivery by adenovirus 5 vectors carrying knobless fibers with antibody-binding domains. Gene Ther. 12, 211-224.
32. Henning, P., Lundgren, E., Carlsson, M., Frykholm, K., Jo-hannisson, J., Magnusson, M.K., Tang, E., Franqueville, L., Hong, S.S., Lindholm, L., and Boulanger, P. (2006). Adeno-virus type 5 fiber knob domain has a critical role in fiber protein synthesis and encapsidation. J. Gen. Virol. 87, 3151-3160.
33. Hensley, S.E., and Amalfitano, A. (2007). Toll-like receptors impact on safety and efficacy of gene transfer vectors. Mol. Ther. 15, 1417-1422.
34. Hoffmann, D., Meyer, B., and Wildner, O. (2007). Improved glioblastoma treatment with Ad5=35 fiber chimeric conditionally replicating adenoviruses. J. Gene Med. 9, 764-778.
35. Hong, S.S., Gay, B., Karayan, L., Dabauvalle, M.C., and Bou-langer, P. (1999). Cellular uptake and nuclear delivery of re-combinant adenovirus penton base. Virology 262, 163-177.
36. Hong, S.S., Magnusson, M.K., Henning, P., Lindholm, L., and Boulanger, P.A. (2003). Adenovirus stripping: A versatile method to generate adenovirus vectors with new cell target specificity. Mol. Ther. 7, 692-699.
37. Hong, S.S., Szolajska, E., Schoehn, G., Franqueville, L., Myhre, S., Lindholm, L., Ruigrok, R.W., Boulanger, P., and Chro-boczek, J. (2005). The 100K-chaperone protein from adenovi-rus serotype 2 (subgroup C) assists in trimerization and nuclear localization of hexons from subgroups C and B ade-noviruses. J. Mol. Biol. 352, 125-138.
38. Iacobelli-Martinez, M., and Nemerow, G.R. (2007). Preferential activation of Toll-like receptor nine by CD46-utilizing adeno-viruses. J. Virol. 81, 1305-1312.
39. Jia, H.P., Look, D.C., Hickey, M., Shi, L., Pewe, L., Netland, J., Farzan, M., Wohlford-Lenane, C., Perlman, S., and McCray, P.B.J. (2006). Infection of human airway epithelia by SARS coronavirus is associated with ACE2 expression and localization. Adv. Exp. Med. Biol. 581, 479-484.
40. Kammouni, W., Moreau, B., Becq, F., Saleh, A., Pavirani, A., Figarella, C., and Merten, M.D. (1999). A cystic fibrosis tra-cheal gland cell line, CF-KM4: Correction by adenovirus-mediated CFTR gene transfer. Am. J. Respir. Cell Mol. Biol. 20, 684-691.
41. Karayan, L., Gay, B., Gerfaux, J., and Boulanger, P. (1994). Oli-gomerization of recombinant penton base of adenovirus type 2 and its assembly with fiber in baculovirus-infected cells. Virology 202, 782-795.
42. Karayan, L., Hong, S.S., Gay, B., Tournier, J., D'Angeac, A.D., and Boulanger, P. (1997). Structural and functional determinants in adenovirus type 2 penton base recombinant protein. J. Virol. 71, 8678-8689.
43. Lecollinet, S., Gavard, F., Havenga, M.J., Spiller, O.B., Lemckert, A., Goudsmit, J., Eloit, M., and Richardson, J. (2006). Improved gene delivery to intestinal mucosa by adenoviral vectors bearing subgroup B and D fibers. J. Virol. 80 2747-2759.
44. Liu, Q., Zaiss, A.K., Colarusso, P., Patel, K., Haljan, G., Wick-ham, T.J., and Muruve, D.A. (2003). The role of capsid-endothelial interactions in the innate immune response to adenovirus vectors. Hum. Gene Ther. 14, 627-643.
45. Magnusson, M.K., Hong, S.S., Boulanger, P., and Lindholm, L. (2001). Genetic retargeting of adenovirus: novel strategy employing " deknobbing" of the fiber. J. Virol. 75, 7280-7289.
46. Magnusson, M.K., Hong, S.S., Henning, P., Boulanger, P., and Lindholm, L. (2002). Genetic retargeting of adenovirus vectors: Functionality of targeting ligands and their influence on virus viability. J. Gene Med. 4, 356-370.
47. Merten, M.D., Kammouni, W., Renaud, W., Birg, F., Mattei, M.G., and Figarella, C. (1996). A transformed human tracheal gland cell line, MM-39, that retains serous secretory functions. Am. J. Respir. Cell Mol. Biol. 15, 520-528.
48. Molinier-Frenkel, V., Lengagne, R., Gaden, F., Hong, S.S., Choppin, J., Gahery-Segard, H., Boulanger, P., and Guillet, J.G. (2002). Adenovirus hexon protein is a potent adjuvant for activation of a cellular immune response. J. Virol. 76, 127-135.
49. Najioullah, F., Thouvenot, D., and Lina, B. (2001). Development of a real-time PCR procedure including an internal control for the measurement of HCMV viral load. J. Virol. Methods 92, 55-64.
50. Nemerow, G.R. (2000a). Adenoviral vectors: New insights. Trends Microbiol. 8, 391-394.
51. Nemerow, G.R. (2000b). Cell receptors involved in adenovirus entry. Virology 274, 1-4.
52. v integrins. Trends Cell Biol. 4, 52-55.
53. Novelli, A., and Boulanger, P. (1991). Deletion analysis of functional domains in baculovirus-expressed adenovirus type 2 fiber. Virology 185, 365-376.
54. Ostedgaard, L.S., Randak, C., Rokhlina, T., Karp, P., Vermeer, D., Excoffon, K.J.A., and Welsh, M.J. (2003). Effects of C-terminal deletions on cystic fibrosis transmembrane conductance regulator function in cystic fibrosis airway epithelia. Proc. Natl. Acad. Sci. U.S.A. 10, 10.
55. Philpott, N.J., Nociari, M., Elkon, K.B., and Falck-Pedersen, E. (2004). Adenovirus-induced maturation of dendritic cells through a PI3 kinase-mediated TNF-a induction pathway. Proc. Natl. Acad. Sci. U.S.A. 101, 6200-6205.
56. Roelvink, P.W., Lizonova, A., Lee, J.G., Li, Y., Bergelson, J.M., Finberg, R.W., Brough, D.E., Kovesdi, I., and Wickham, T.J. (1998). The coxsackievirus-adenovirus receptor protein can function as a cellular attachment protein for adenovirus sero-types from subgroups A, C, D, E, and F. J. Virol. 72, 7909-7915.
57. 1 is an alternative receptor for adenovirus serotype 5. J. Virol. 77, 13448-13454.
58. Seth, P. (1994). Adenovirus-dependent release of choline from plasma membrane vesicles at an acidic pH is mediated by the penton base protein. J. Virol. 68, 1204-1206.
59. Seth, P., Fitzgerald, D., Ginsberg, H., Willingham, M., and Pa-stan, I. (1984). Evidence that the penton base of adenovirus is involved in potentiation of toxicity of Pseudomonas exotoxin conjugated to epidermal growth factor. Mol. Cell. Biol. 4, 1528-1533.
60. Seth, P., Pastan, I., and Willingham, M.C. (1985). Adenovirus-dependent increase in cell membrane permeability. J. Biol. Chem. 260, 9598-9602.
61. Shayakhmetov, D.M., Eberly, A.M., Li, Z.Y., and Lieber, A. (2005). Deletion of penton RGD motifs affects the efficiency of both the internalization and the endosome escape of viral particles containing adenovirus serotype 5 or 35 fiber knobs. J. Virol. 79, 1053-1061.
62. Sinn, P.L., Williams, G., Vongpunsawad, S., Cattaneo, R., and McCray, P.B.J. (2002). Measles virus preferentially transduces the basolateral surface of well-differentiated human airway epithelia. J. Virol. 76, 2403-2409.
63. Stewart, P.L., and Nemerow, G.R. (2007). Cell integrins: Commonly used receptors for diverse viral pathogens. Trends Microbiol. 15, 500-507.
64. Thorne, P.S., McCray, P.B., Howe, T.S., and O'Neill, M.A. (1999). Early-onset inflammatory responses in vivo to adenoviral vectors in the presence or absence of lipopolysaccharide-induced inflammation. Am. J. Respir. Cell Mol. Biol. 20, 1155-1164.
65. Toyoda, E., Doi, R., Kami, K., Mori, T., Ito, D., Koizumi, M., Kida, A., Nagai, K., Ito, T., Masui, T., Wada, M., Tagawa, M., and Uemoto, S. (2008). Adenovirus vectors with chimeric type 5 and 35 fiber proteins exhibit enhanced transfection of human pancreatic cancer cells. Int. J. Oncol. 33, 1141-1147.
66. Tuve, S., Wang, H., Jacobs, J.D., Yumul, R.C., Smith, D.F., and Lieber, A. (2008). Role of cellular heparan sulfate proteogly-cans in infection of human adenovirus serotype 3 and 35. PLoS Pathogens 4, e1000189.
67. Van Tol, M.J., Kroes, A.C.M., Schinkel, J., Dinkelaar, W., Claas, E.C.J., Jol-Van Der Zijde, C.M., and Vossen, J.M. (2005). Adenovirus infection in paediatric stem cell transplant recipients: Increased risk in young children with a delayed immune recovery. Bone Marrow Transplant. 36, 39-50.
68. Venglarik, C.J., Bridges, R.J., and Frizzell, R.A. (1990). A simple assay for agonist-regulated Cl and K conductances in salt-secreting epithelial cells. Am. J. Physiol. 259, C358-C364.
69. Vermeer, P.D., McHugh, J., Rokhlina, T., Vermeer, D.W., Zab-ner, J., and Welsh, M.J. (2007). Vaccinia virus entry, exit, and interaction with differentiated human airway epithelia. J. Virol. 81, 9891-9899. (Erratum in: J. Virol. 2007;9881:13278).
70. Walters, R.W., Grunst, T., Bergelson, J.M., Finberg, R.W., Welsh, M.J., and Zabner, J. (1999). Basolateral localization of fiber receptors limits adenovirus infection from the apical surface of airway epithelia. J. Biol. Chem. 274, 10219-10226.
71. Walters, R.W., Freimuth, P., Moninger, T.O., Ganske, I., Zabner, J., and Welsh, M.J. (2002). Adenovirus fiber disrupts CAR-mediated intercellular adhesion allowing virus escape. Cell 110, 789-799.
72. Wang, G., Li, G., Liu, H., Yang, C., Yang, X., Jin, J., Liu, X., Qian, Q., and Qian, W. (2009). E1B 55-kDa deleted, Ad5=F35 fiber chimeric adenovirus, a potential oncolytic agent for B-lymphocytic malignancies. J. Gene Med. 11, 477-485.
73. Waszak, P., Franqueville, L., Franco-Motoya, M.-L., Rosa-Calatrava, M., Boucherat, O., Lindholm, L., Delacourt, C., and Boulanger,P. (2007). Toxicity offiber-and penton base-modified adenovirus type 5 vectors on lung development in newborn rats. Mol. Ther. 15, 2008-2016.
74. 5 promote adenovirus internali-zation but not virus attachment. Cell 73, 309-319.
75. 5 selectively promotes adenovirus mediated cell membrane permeabilization. J. Cell Biol. 127, 257-264.
76. Wickham, T.J., Carrion, M.E., and Kovesdi, I. (1995). Targeting of adenovirus penton base to new receptors through replacement of its RGD motif with other receptor-specific peptide motifs. Gene Ther. 2, 750-756.
77. Wu, E., Trauger, S.A., Pache, L., Mullen, T.M., Von Seggern, D.J., and Nemerow, G.R. (2004). Membrane cofactor protein is a receptor for adenoviruses associated with epidemic kerato-conjunctivitis. J. Virol. 78, 3897-3905.
78. Zabner, J., Zeiher, B.G., Friedman, E., and Welsh, M.J. (1996). Adenovirus-mediated gene transfer to ciliated airway epithe-lia requires prolonged incubation time. J. Virol. 70, 6994-7003.
79. Zabner, J., Chillon, M., Grunst, T., Moninger, T.O., Davidson, B.L., Gregory, R., and Armentano, D. (1999). A chimeric type 2 adenovirus vector with a type 17 fiber enhances gene transfer to human airway epithelia. J. Virol. 73, 8689-8695.
80. Zabner, J., Scheetz, T.E., Almabrazi, H.G., Casavant, T.L., Huang, J., Keshavjee, S., and McCray, P.B.J. (2005). CFTR DF508 mutation has minimal effect on the gene expression profile of differentiated human airway epithelia. Am. J. Phy-siol. Lung Cell Mol. Physiol. 289, L545-L553.
81. Zhang, L., Button, B., Gabriel, S.E., Burkett, S., Yan, Y., Skiado-poulos, M.H., Dang, Y.L., Vogel, L.N., McKay, T., Mengos, A., Boucher, R.C., Collins, P.L., and Pickles, R.J. (2009). CFTR delivery to 25% of surface epithelial cells restores normal rates of mucus transport to human cystic fibrosis airway epithelium. PLoS Biol. 7, e1000155.